In this session, Dr Sam Klempner from Massachusetts General Hospital discusses the use of circulating tumor DNA (ctDNA) testing to monitor for minimal residual disease (MRD) in GI cancer.

In this session, Dr Josh Smith from Memorial Sloan Kettering Cancer Center provides an update on rectal cancers from the major meetings last year.

In this session, Dr Nina Sanford from UT Southwestern provides an update on rectal cancers from the major meetings last year.

In this session, Dr Anthony Magliocco from Protean BioDiagnostics considers the burgeoning topic of cancer diagnostics, including gene panels, liquid biopsy methods and genetic testing.

In this session, Dr Jaydira Del Rivero from National Cancer Institute provides relevant updates on neuroendocrine tumors.

In this session, Dr Misagh Karimi from City of Hope provides relevant updates on gastric and esophageal cancers.

In this session, Dr Kristen Ciombor from Vanderbilt-Ingram Cancer Center provides relevant updates on the use of immunotherapy in colorectal cancers.

In this session, Dr Mohamed Salem from Levine Cancer Institute considers relevant updates for colon, rectal and anal cancers.